Akos Czibere

CIK: 0002049427

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AKTS

Aktis Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

AKTS
Aktis Oncology, Inc.
Sep 23, 2026
Exercise(M)
Direct
12.5K shares at avg. $4.95$62K
AKTS
Aktis Oncology, Inc.
Sep 23, 2026
Sale(S)
Direct
5.1K shares at avg. $20.19$103K
AKTS
Aktis Oncology, Inc.
Sep 23, 2026
Sale(S)
Direct
7.4K shares at avg. $21.03$156K
AKTS
Aktis Oncology, Inc.
Jul 8, 2026
Exercise(M)
Direct
50K shares at avg. $4.95$248K
AKTS
Aktis Oncology, Inc.
Jul 8, 2026
Sale(S)
Direct
4.4K shares at avg. $28.71$125K
AKTS
Aktis Oncology, Inc.
Jul 8, 2026
Sale(S)
Direct
14.8K shares at avg. $27.13$401K
AKTS
Aktis Oncology, Inc.
Jul 8, 2026
Sale(S)
Direct
30.8K shares at avg. $27.95$862K

		Type	Shares	Price		Ownership
Sep 23, 2026	AKTS Aktis Oncology, Inc.	Exercise(M)	12,500	$4.95	$61,875	Direct
Sep 23, 2026	AKTS Aktis Oncology, Inc.	Sale(S)	5,099	$20.19	$102,973	Direct
Sep 23, 2026	AKTS Aktis Oncology, Inc.	Sale(S)	7,401	$21.03	$155,648	Direct
Jul 8, 2026	AKTS Aktis Oncology, Inc.	Exercise(M)	50,000	$4.95	$247,500	Direct
Jul 8, 2026	AKTS Aktis Oncology, Inc.	Sale(S)	4,371	$28.71	$125,482	Direct
Jul 8, 2026	AKTS Aktis Oncology, Inc.	Sale(S)	14,800	$27.13	$401,484	Direct
Jul 8, 2026	AKTS Aktis Oncology, Inc.	Sale(S)	30,829	$27.95	$861,735	Direct

1-7 of 7 transactions

About Czibere Akos

Czibere Akos (SEC CIK 0002049427) files insider reports with the SEC as Chief Medical Officer of Aktis Oncology, Inc. (AKTS).

Signal8 holds 3 ownership filings by Czibere Akos (1 Form 3, 2 Form 4), filed between Jan 8, 2026 and Sep 24, 2026. Those filings report 7 transactions, from Jul 8, 2026 to Sep 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Czibere Akos's filings is in BOSTON, MA.

Recent filings by Czibere Akos

Sep 23, 2026: Option exercise of AKTS shares (Form 4, code M).
Sep 23, 2026: Open-market sales of AKTS shares (2 lines, Form 4, code S).
Jul 8, 2026: Option exercise of AKTS shares (Form 4, code M).
Jul 8, 2026: Open-market sales of AKTS shares (3 lines, Form 4, code S).

Other insiders filing for Aktis Oncology, Inc. (AKTS)

Herrmann Ken, Director
Ron-Bigger Shulamit, Chief Operating Officer
Gormley Glenn, Director
ELI LILLY & Co, 10% Owner
Foley Todd, Director
MPM BIOVENTURES 2018, L.P., 10% Owner

How to read Form 4 transaction codes